This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Infiltration anaesthesia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Local anaesthetic is injected subcutaneously. It acts on local nerve endings. Lignocaine 0.5% is the most commonly used agent, and it is often combined with adrenaline to retard dispersion and increase the local dose that may be given without systemic toxicity.

Infiltration anaesthesia is frequently used postoperatively around the site of a wound. Preoperatively, large volumes of weak local anaesthetic and adrenaline can be used to force apart tissue planes before the first incision.

Some practical considerations:

  • know the maximal volume of the anaesthetic that may safely be injected for the patient's size
  • repeatedly aspirate to ensure the needle is not intravascularly-sited
  • after the initial injection, further injections should be made through the same area to the surroundings with a long needle
  • always inject anaesthetic after insertion of the needle to the hilt and while it is being withdrawn
  • when infiltrating dirty wounds, it may be preferable to inject through the skin rather than the wound edges
  • adrenaline with local anaesthetic should be avoided in sites such as the digits and penis

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.